BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32950295)

  • 1. Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Fredrik Liedberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.033.
    Liedberg F; Kollberg P; Allerbo M; Baseckas G; Brändstedt J; Gudjonsson S; Hagberg O; Håkansson U; Jerlström T; Löfgren A; Patschan O; Sörenby A; Bläckberg M
    Eur Urol; 2020 Nov; 78(5):e186-e187. PubMed ID: 32950295
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Fredrik Liedberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.033.
    Ghoreifi A; Djaladat H
    Eur Urol; 2020 Nov; 78(5):e184-e185. PubMed ID: 32951928
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Fredrik Liedberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol 2020;78:757-63.
    Bansal A; Maheshwari R; Kumar A
    Eur Urol; 2021 Mar; 79(3):e78. PubMed ID: 33419678
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Amit Bansal, Ruchir Maheshwari, and Anant Kumar's Letter to the Editor re: Fredrik Liedberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol 2020;78:757-63.
    Liedberg F; Kollberg P; Allerbo M; Baseckas G; Brändstedt J; Gudjonsson S; Hagberg O; Håkansson U; Jerlström T; Löfgren A; Patschan O; Sörenby A; Bläckberg M
    Eur Urol; 2021 Mar; 79(3):e79-e80. PubMed ID: 33390285
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Deepansh Dalela, Isaac Palma-Zamora, and Craig Rogers' Letter to the Editor re: Fredrick Leidberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol 2020;78:757-63.
    Liedberg F; Kollberg P; Allerbo M; Baseckas G; Brändstedt J; Gudjonsson S; Hagberg O; Håkansson U; Jerlström T; Löfgren A; Patschan O; Sörenby A; Bläckberg M
    Eur Urol; 2021 Apr; 79(4):e117-e118. PubMed ID: 33509649
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Fredrick Leidberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol 2020;78:757-63.
    Dalela D; Palma-Zamora I; Rogers C
    Eur Urol; 2021 Apr; 79(4):e115-e116. PubMed ID: 33487478
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.
    Shapiro DD; Karam JA; Master VA; Zemp LW; Sexton WJ; Matin SF; Spiess PE; Jason Abel E
    Eur Urol; 2023 Aug; 84(2):e55-e56. PubMed ID: 37149462
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
    Tachibana I; Kern SQ; Douglawi A; Tong Y; Mahmoud M; Masterson TA; Adra N; Foster RS; Einhorn LH; Cary C
    Eur Urol; 2023 Jan; 83(1):e20-e21. PubMed ID: 36195478
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study.
    Liedberg F; Kollberg P; Allerbo M; Baseckas G; Brändstedt J; Gudjonsson S; Hagberg O; Håkansson U; Jerlström T; Löfgren A; Patschan O; Sörenby A; Bläckberg M
    Eur Urol; 2020 Nov; 78(5):757-763. PubMed ID: 32800407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic surgical mesh placement as a prevention of parastomal hernia in open radical cystectomy with ileal conduit diversion - pilot study.
    Louda M; Navrátil P; Šachová Š; Holub L; Fibír A; Balík M; Broďák M
    Rozhl Chir; 2024; 103(3):91-95. PubMed ID: 38886103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parastomal hernias after radical cystectomy and ileal conduit diversion.
    Donahue TF; Bochner BH
    Investig Clin Urol; 2016 Jul; 57(4):240-8. PubMed ID: 27437533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How-I-do-it: minimally invasive repair of ileal conduit parastomal hernias.
    Dewulf M; Pletinckx P; Nachtergaele F; Ameye F; Dekuyper P; Hildebrand N; Muysoms F
    Langenbecks Arch Surg; 2022 May; 407(3):1291-1301. PubMed ID: 35088143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parastomal hernia after ileal conduit with a prophylactic mesh: a 10 year consecutive case series.
    Styrke J; Johansson M; Granåsen G; Israelsson L
    Scand J Urol; 2015; 49(4):308-12. PubMed ID: 25656978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023.
    Stattin P; Bratt O
    Eur Urol; 2017 Apr; 71(4):e115-e116. PubMed ID: 27720538
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Rodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, and Gregor Mikuz's Letter to the Editor re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017. Focus on Our Personal Recollections and Observations.
    van der Kwast T; Van Rhijn B; Kamat A; Cheng L
    Eur Urol Focus; 2022 May; 8(3):885-886. PubMed ID: 33992577
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Can Lu and Xiao Guan's Letter to the Editor re: Marko Babjuk. Are the Role of Surgery and its Complications Sufficiently Focused in the Era of Perioperative Systemic Treatments? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.01.022.
    Babjuk M
    Eur Urol; 2020 Aug; 78(2):e73-e74. PubMed ID: 32389446
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues.
    Trock BJ; Karnes RJ
    Eur Urol; 2017 Dec; 72(6):e158-e159. PubMed ID: 28576503
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Sungeun Kim, Jae Il Shin, and Jonathan Evan Shoag's Letter to the Editor re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010.
    Valle LF; Kishan AU
    Eur Urol; 2021 Jul; 80(1):e15-e16. PubMed ID: 33934928
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Feng Qi, Zicheng Xu, and Qing Zou's Letter to the Editor re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010.
    Loehr A; Chowdhury S; Abida W
    Eur Urol; 2023 Mar; 83(3):e78. PubMed ID: 36623951
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012.
    Kerkmeijer LGW; Pos FJ; van der Heide UA; Israël B; Draulans C; Haustermans K
    Eur Urol; 2022 Jun; 81(6):e147-e148. PubMed ID: 35339319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.